Financhill
Back

Cardiff Oncology 10K Form

Buy
58

CRDF
Cardiff Oncology

Last Price:
$4.14
Seasonality Move:
13.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRDF News And Ratings

See the #1 stock for the next 7 days that we like better than CRDF

CRDF Financial Statistics

Sales & Book Value

Annual Sales: $683K
Cash Flow: $-12.8M
Price / Cash Flow: 0
Annual Sales: $1.07
Price / Book: 3.82

Profitability

EPS (TTM): -0.92000
Net Income (TTM): $-48.9M
Gross Margin: $240K
Return on Equity: -77.18%
Return on Assets: -63.45%

Cardiff Oncology Earnings Forecast

Key Cardiff Oncology Financial Ratios

  • The Gross Profit Margin over the past 10 years for CRDF is 98.11%.
  • The Selling, General & Administrative Expenses for CRDF have been equal to 1,827.53% of Gross Profit Margin.
  • The Research & Development expenses have been 5,395.61% of Revenue.
  • The Net Earning history of CRDF is -6,651.68% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 7 years.

Cardiff Oncology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRDF
CUSIP: 14147L
Website: cardiffoncology.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.22
Quick Ratio: 6.04

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRDF Technical Analysis vs Fundamental Analysis

Buy
58
Cardiff Oncology (CRDF) is a Buy

Is Cardiff Oncology a Buy or a Sell?

  • Cardiff Oncology stock is rated a Buy
    The current Cardiff Oncology [CRDF] share price is $4.07. The Score for CRDF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.